Based on product type, the pulse oximeter category is expected to witness the faster growth, with a CAGR of 8.6%, during the forecast period, owing to the rising demand for these devices and increasing prevalence of various types of chronic diseases.
Increasing Number of Acquisitions is a Key Trend in Pulse and Regional Oximeters Market
An increasing number of acquisitions and collaborations among players, to expand their footprint and consumer base, is being observed in the pulse and regional oximeters market. Market players, such as Edwards Lifesciences Corporation and Koninklijke Philips N.V., are actively involved in strategic activities to expand their product portfolio and market share.
Request to Get Free Sample Pages at:
For instance, in April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems Inc. (CASMED) for approximately $100 million. The objective of this acquisition was to pair CASMED's FORE-SIGHT non-invasive cerebral oxygenation technology with Edwards Lifesciences Corporation’s HemoSphere advanced hemodynamic monitoring platform. The assembly helps create enhanced recovery tools and predictive analytics capabilities for clinics.
The players in the market are adopting several strategic measures, such as product launches and collaborations and partnerships, to maintain their position. For example, in in March 2019, Masimo Corporation received the U.S. Food and Drug Administration (FDA) clearance for its RAD-67 pulse co-oximeter. The device is equipped with the spot-check next-generation noninvasive total hemoglobin (SpHb) monitoring technology and the rainbow DCI-mini reusable sensor. The device provides portable spot-check monitoring measurements of oxygen saturation, which makes it a single-device solution in multiple clinical and non-clinical settings.
Some other important players operating in the pulse and regional oximeters market are Smiths Medical Inc., Opto Circuits Limited, Nonin Medical Inc., Halma Plc, and Spacelabs Healthcare.
